Compounds > 1,7-phenanthroline
Page last updated: 2024-08-24

1,7-phenanthroline and Myotonic Dystrophy

1,7-phenanthroline has been researched along with Myotonic Dystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dohno, C; Kiliszek, A; Li, J; Matsumoto, J; Murata, A; Nakamori, M; Nakatani, K; Sobczak, K; Taylor, K1
Bai, LP; Dohno, C; Li, J; Matsumoto, J; Murata, A; Nakatani, K1

Other Studies

2 other study(ies) available for 1,7-phenanthroline and Myotonic Dystrophy

ArticleYear
A Dimeric 2,9-Diamino-1,10-phenanthroline Derivative Improves Alternative Splicing in Myotonic Dystrophy Type 1 Cell and Mouse Models.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Dec-05, Volume: 24, Issue:68

    Topics: Alternative Splicing; Animals; Disease Models, Animal; DNA-Binding Proteins; Drug Discovery; Humans; Ligands; Mice; Myotonic Dystrophy; Phenanthrolines; RNA-Binding Proteins; RNA, Messenger

2018
A Ligand That Targets CUG Trinucleotide Repeats.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2016, Oct-10, Volume: 22, Issue:42

    Topics: Humans; Ligands; Myotonic Dystrophy; Phenanthrolines; RNA; RNA Splicing; RNA-Binding Proteins; Trinucleotide Repeat Expansion; Trinucleotide Repeats

2016